Skip to main content

Table 1 Baseline characteristics across prescriber adoption categories

From: Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

Adoption CategoryLaggards n = 1077(SD)Late Majority n = 2273Early Majority n = 2294Early Adopters n = 915Innovators n = 153
RegionsΔ n (%)
 Northeast327 (15.1%)721 (33.4%)756 (35.0%)308 (14.3%)49 (2.3%)
 Midwest165 (17.5%)327 (34.6%)318 (33.7%)117 (12.4%)18 (1.9%)
 South403 (16.0%)878 (34.8%)840 (33.3%)345 (13.7%)56 (2.2%)
 West182 (16.8%)347 (32.0%)380 (35.1%)145 (13.4%)30 (2.8%)
Gender* n (%)
 Female317 (16.8%)657 (34.8%)581 (30.8%)279 (14.8%)52 (2.8%)
Specialty Category** n (%)
 Primary Care291 (17.3%)613 (36.4%)494 (29.3%)239 (14.2%)48 (2.8%)
 Regular Specialists (other than Infectious Disease specialists, and Gastroenterologists & Hepatologists)58 (14.3%)158 (38.9%)136 (33.5%)46 (11.3%)8 (2.0%)
 Infectious Disease Specialists126 (18.6%)227 (33.5%)224 (33.0%)87 (12.8%)14 (2.1%)
 Gastroenterologists & Hepatologists602 (15.3%)1275 (32.3%)1440 (36.5%)543 (13.8%)83 (2.1%)
Median Income (by Zip Code)Δ
 Median Income (by Zip Code)5.83 (2.63)5.87 (2.69)5.77 (2.59)5.99 (2.90)6.32 (2.95)
  1. Δp - NS; * p < 0.05; ** p < < 0.01
\